Concepedia

Emily K. Kleczko

EK

Statistics

Publications

17

Citations

841

H-Index

14

Active since

2013

Affiliations

University of Colorado Anschutz Medical Campus(Current)

VA Eastern Colorado Health Care System

University of Colorado Denver

University Hospital Bonn

Hypertension Institute

Emily K. Kleczko is an author at University of Colorado Anschutz Medical Campus specializing in medicine, oncology, and immunology.

Publications per year

2013–2023

17

Publications

17

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

K E Ware, Trista K. Hinz, Emily K. Kleczko et al. · Oncogenesis · 2013 · 256 citations · Full text

Medicine, Oncology, Pharmacology +17

FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers

Friederike Göke, Alina Franzen, Trista K. Hinz et al. · Clinical Cancer Research · 2015 · 85 citations · Full text

Medicine, Molecular Biology, Oncology +17

CD8+ T cells modulate autosomal dominant polycystic kidney disease progression

Emily K. Kleczko, Kenneth H. Marsh, Logan C. Tyler et al. · Kidney International · 2018 · 75 citations · Full text

Medicine, Immunology, Nephrology +12

Kinome RNAi Screens Reveal Synergistic Targeting of MTOR and FGFR1 Pathways for Treatment of Lung Cancer and HNSCC

Katherine R. Singleton, Trista K. Hinz, Emily K. Kleczko et al. · Cancer Research · 2015 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17

Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms

Alexander Neuwelt, Abigail K. Kimball, Amber M. Johnson et al. · Journal for ImmunoTherapy of Cancer · 2020 · 51 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 17